These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15888431)

  • 21. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders.
    Sarter M; Bruno JP
    Trends Neurosci; 1999 Feb; 22(2):67-74. PubMed ID: 10092046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparate cholinergic currents in rat principal trigeminal sensory nucleus neurons mediated by M1 and M2 receptors: a possible mechanism for selective gating of afferent sensory neurotransmission.
    Kohlmeier KA; Soja PJ; Kristensen MP
    Eur J Neurosci; 2006 Jun; 23(12):3245-58. PubMed ID: 16820015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
    Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotogenic properties of benzodiazepine receptor inverse agonists.
    Sarter M; Bruno JP; Berntson GG
    Psychopharmacology (Berl); 2001 Jun; 156(1):1-13. PubMed ID: 11465627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice.
    Sigala S; Zoli M; Palazzolo F; Faccoli S; Zanardi A; Mercuri NB; Spano P
    Neuroscience; 2007 Feb; 144(3):834-44. PubMed ID: 17112676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.
    Brooks JM; Sarter M; Bruno JP
    Neuropsychopharmacology; 2011 Nov; 36(12):2477-87. PubMed ID: 21814184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amphetamine-induced sensitized state as a model of schizophrenia.
    Featherstone RE; Kapur S; Fletcher PJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1556-71. PubMed ID: 17884274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome.
    Barak S
    Behav Brain Res; 2009 Dec; 204(2):335-51. PubMed ID: 19376161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior parietal cortex as part of a neural network for directed attention in rats.
    Reep RL; Corwin JV
    Neurobiol Learn Mem; 2009 Feb; 91(2):104-13. PubMed ID: 18824116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline transporters, cholinergic transmission and cognition.
    Sarter M; Parikh V
    Nat Rev Neurosci; 2005 Jan; 6(1):48-56. PubMed ID: 15611726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Tanaka S
    Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
    Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?
    Sarter M
    Psychopharmacology (Berl); 1994 May; 114(4):539-50. PubMed ID: 7855215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
    Luques L; Shoham S; Weinstock M
    Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity.
    Parikh V; Sarter M
    Ann N Y Acad Sci; 2008; 1129():225-35. PubMed ID: 18591483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.